Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
The Phase 2 trial data confirms this: the 1mg dose group achieved only 8.7% weight loss at 48 weeks, indicating that low doses produce modest effects that accumulate slowly
Upon transfection, anti- GLS1 siRNA led to the knockdown of GLS1 , increased cell death and induced alterations in the metabolic profile The knockdown of GLS1 gene was confirmed until 96 h after transfection with anti- GLS1 siRNAs (Fig
TB-500, an actin-binding protein, helps keep actin in specific locations to allow cell migration (2)
Olsen, E.A., et al
US$ 29.40
US$ 21.57
US$ 27.19
US$ 22.51
US$ 24.87
US$ 26.95
US$ 24.13
US$ 29.21
US$ 25.43
